Tissue scaffolds are essential for tissue engineering because they must provide a proper mechanical and chemical environment for seeded cells to grow and operate normally, eventually forming completely functioning tissue. Tissue scaffolds essentially serve two purposes: they give a place for cells to multiply and they have a structure that allows soluble gases, nutrients, and waste products to be transported in a way that satisfies the needs of an expanding cell population. Scaffolds for tissue engineering can also be made from natural materials and are generally biocompatible. For tissue engineering purposes, a variety of materials have been produced as scaffolds. Foaming is used to create scaffolds that most closely fulfill the parameters for an ideal scaffold and most closely mirror the structure of trabecular bone. Biocompatibility is the most important feature of TE scaffolds. Biocompatibility can be defined as a biomaterial's, device's, or system's capacity to fulfil its intended function in relation to a medical therapy without causing any undesired local or systemic consequences in the therapy's recipient or beneficiary. More specifically, a scaffold's biocompatibility for TE applications relates to its capacity to function as a substrate that will support the desired cellular activity.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Cellular and molecular profiling of critical bone fractures in axolotl
Polikarpova Anastasia, The Institute of Molecular Pathology, Austria